Merck Canada

Kirkland, Quebec H9H 4M7

0 studies enrolling now · 1 studies all time

What they study most

Colorectal Cancer, Neoplasms

Studies at this site

• Study of MK-8353 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Malignancies (MK-8353-013) — Stopped early